Search Results - "BABOVIC, N"

PO-075: Treatment of nasopharyngeal cancer: a Serbian institututinal experience by Ursulovic, T, Babovic, N

Get full text

Access to innovative medicines for metastatic melanoma worldwide: Melanoma World Society and European Association of Dermato-oncology survey in 34 countries by Kandolf Sekulovic, L., Guo, J., Agarwala, S., Hauschild, A., McArthur, G., Cinat, G., Wainstein, A., Caglevic, C., Lorigan, P., Gogas, H., Alvarez, M., Duncombe, R., Lebbe, C., Peris, K., Rutkowski, P., Stratigos, A., Forsea, A.-M., De La Cruz Merino, L., Kukushkina, M., Dummer, R., Hoeller, C., Gorry, C., Bastholt, L., Herceg, D., Neyns, B., Vieira, R., Arenberger, P., Bylaite-Bucinskiene, M., Babovic, N., Banjin, M., Putnik, K., Todorovic, V., Kirov, K., Ocvirk, J., Zhukavets, A., Ymeri, A., Stojkovski, I., Garbe, C.

“…According to data from recent studies from Europe, a large percentage of patients have restricted access to innovative medicines for metastatic melanoma…”
Get full text

More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments by Kandolf Sekulovic, L, Peris, K, Hauschild, A, Stratigos, A, Grob, J.-J, Nathan, P, Dummer, R, Forsea, A.-M, Hoeller, C, Gogas, H, Demidov, L, Lebbe, C, Blank, C, Olah, J, Bastholt, L, Herceg, D, Neyns, B, Vieira, R, Hansson, J, Rutkowski, P, Krajsova, I, Bylaite-Bucinskiene, M, Zalaudek, I, Maric-Brozic, J, Babovic, N, Banjin, M, Putnik, K, Weinlich, G, Todorovic, V, Kirov, K, Ocvirk, J, Zhukavets, A, Kukushkina, M, De La Cruz Merino, L, Ymeri, A, Risteski, M, Garbe, C

“…Abstract Background Despite the efficacy of innovative treatments for metastatic melanoma, their high costs has led to disparities in cancer care among…”
Get full text

1102 In Vitro Enhancement of NK Cell Activity of Metastatic Melanoma Patients With IFN-alpha Alone as Opposed to its Combination With 13-cis Retinoic Acid is Associated With Modulation of NKG2D and CD161 Activating Receptor Expression by Konjevic, G, Mirjacic-Martinovic, K, Vuletic, A, Babovic, N

Get full text

Phase II trial of pirfenidone in adults with neurofibromatosis type 1 by BABOVIC-VUKSANOVIC, D, BALLMAN, K, SPINNER, R, O'NEILL, B, MICHELS, V, MCGRANN, P, LINDOR, N, KING, B, CAMP, J, MICIC, V, BABOVIC, N, CARRERO, X

“…We performed an open-label phase II trial of oral pirfenidone in 24 patients with neurofibromatosis type 1 (NF1). Tumors were monitored by three-dimensional…”
Get full text

In vitro increased natural killer cell activity of metastatic melanoma patients with interferon-α alone as opposed to its combination with 13-cis retinoic acid is associated with modulation of NKG2D and CD161 activating receptor expression by Konjevic, G, Mirjacic-Martinovic, K, Vuletic, A, Babovic, N

“…Considering tumor-induced suppression of natural killer (NK) cell activity the aim of this study was to investigate the in vitro effect of a standard…”
Get more information

302 The effect of differential in vitro regulation of NKG2D and CD161 NK cell receptors by IL-2 or IFN-a on activation of NK cells in metastatic melanoma patients by Konjevic, G, Mirjacic Martinovic, K, Vuletic, A, Babovic, N

Get full text

Primary non-Hodgkin lymphoma of the breast. Is it possible to avoid mastectomy? by Babovic, N, Jelic, S, Jovanovic, V

“…Primary lymphoma of the breast is a rare disease that has been estimated to represent from 0.05% to 0.53% of all malignant breast tumors and approximately 2.2%…”
Get more information

Survival advantage for carboplatin substituting cisplatin in combination with vindesine and mitomycin C for stage IIIB and IV squamous-cell bronchogenic carcinoma: a randomized phase III study by Jelić, Svetislav, Mitrović, Labuda, Radosavljević, Davorin, Elezar, Elizabeta, Babović, Nada, Kovčin, Vladimir, Tomašević, Zoran, Kovačević, Svetlana, Gavrilović, Dušica, Radulović, Siniša

“…This communication represents the definitive report of a randomized phase III study comparing cisplatin and carboplatin, in combination with vindesine and…”
Get full text

Randomised study of high-dose epirubicin versus high-dose epirubicin-cisplatin chemotherapy for advanced soft tissue sarcoma by JELIC, S, KOVCIN, V, MILANOVIC, N, BABOVIC, N, KREACIC, M, RISTOVIC, Z, VLAJIC, M, FILIPOVIC-LJESKOVIC, I

“…A randomised study was started in chemotherapy-naive patients with advanced soft tissue sarcomas who received either epirubicin 60 mg/m 2/24 h (total dose for…”
Get full text

1054 The existence of humoral immunity to gliadin and cow's milk proteins in patients with prostatic diseases by Besu, I, Juranic, Z, Djordjevic, M, Konic-Ristic, A, Filipovic-Ljeskovic, I, Babovic, N, Jelic, S

Get full text

5551 POSTER Impact of Cisplatin potentiation by Cytarabine in the 5-FU-CDDP regimen for dismal-prognosis head and neck cancer (HNC) patients; a meta-analysis of 3 local trials involving 492 patients by Jelic, S, Kreacic, M, Ursulovic, T, Vucicevic, S, Gavrilovic, D, Jovanovic, N, Babovic, N, Petrovic, Z, Mikic, A

Get full text

Use of high-dose cytarabine to enhance cisplatin cytotoxicity—effects on the response and overall survival rates of advanced head and neck cancer patients by JELIC, S, STAMATOVIC, Lj, VUCICEVIC, S, PETROVIC, Z, KREACIC, M, BABOVIC, N, JOVANOVIC, N, MIKIC, A, GAVRILOVIC, D

“…It has been reported that cytarabine, acting by at least two different mechanisms, enhances the cytotoxic effect of cisplatin in in vitro systems. The aim of…”
Get full text

Comparison of the efficacy of two different dosage dacarbazine-based regimens and two regimens without dacarbazine in metastatic melanoma: a single-centre randomized four-arm study by Jelić, S, Babovic, N, Kovcin, V, Milicevic, N, Milanovic, N, Popov, I, Radosavljevic, D

“…The aim of this randomized four-arm phase III study was to evaluate whether there is a difference in activity between regimens containing dacarbazine and…”
Get full text

Antimelanoma immunity in vitiligo and melanoma patients by Juranic, Z D, Stanojevic-Bakic, N, Zizak, Z, Babovic, N, Radovic-Kovacevic, V, Stanojkovic, T, Dzodic, R

“…Cutaneous melanoma and vitiligo are diseases etiology of which evolves around melanocytes. The nature of immunological disturbances associated with these…”
Get more information

Vinblastin-carboplatin for metastatic cutaneous melanoma as first-line chemotherapy and in dacarbazine failures: a single-center study by Jelić, S, Babović, N, Stamatović, L, Kreacić, M, Matković, S, Popov, I

“…First-line treatments of metastatic melanoma are usually decarbazine (DTIC) and/or alpha-interferon based, with response rates in the range of at most 20-30%…”
Get full text

Pilot study of daily ifosfamide 1 g/m2 until grade III granulocytopenia as second-line chemotherapy for anthracycline-pretreated advanced soft tissue sarcoma by Babović, N, Jelić, S, Milanović, N, Matković, S

“…Second-line chemotherapy regimens for advanced soft tissue sarcomas after treatment failure or tumor relapse following anthracyclines are still…”
Get more information

S84 RATIONALE FOR SURGICAL CASTRATION IN PATIENTS WITH METASTATIC PROSTATE CANCER by Vukotic, V, Lazic, M, Babovic, N, Matkovic, S, Filipovic, N, Kojic, D, Spasic, D

Get full text

A pilot study to assess the efficacy of salmon calcitonin in the relief of neuropathic pain caused by extraskeletal metastases by Kovcin, V, Jelić, S, Babović, N, Tomasević, Z

“…Although the pain-relieving activity of salmon calcitonin has been mainly demonstrated for painful bone metastases it has been postulated that the drug…”
Get full text

Association of Impaired NK Cell Activity with Imbalance in CD3-CD16+ Bright and Dim Subset Distribution and Receptor Expression in Metastatic Melanoma Patients by Konjevic, G, Mirjacic Martinovic, K, Vuletic, A, Babovic, N

Get full text